Company

Gynesonics

Rocket Ship Rating

Rocket Ship Rating: 97 out of 100

Gynesonics’ Sonata® System is an incision-free option for treating symptomatic uterine fibroids.

Women's & family health

Business model: B2B
Legal name: Gynesonics, Inc.

gynesonics.com (opens in a new tab)

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Gynesonics’ Sonata® System is an incision-free option for treating symptomatic uterine fibroids.

Funding snapshot

Total raised: $299MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $92.2M2023-04-06

Funding rounds

Round, 2023: $92.2M2023-04-06, SEC form D sold, 13 investors
Round, 2021: $32.5M2021-12-15, SEC form D sold, 18 investors
Round, 2018: $75.5M2018-12-18, SEC form D sold, 21 investors
Round, 2015: $43.1M2015-07-14, SEC form D sold, 16 investors
Round, 2015: $3M2015-04-09, SEC form D sold, 12 investors
Round, 2013: $28.4M2013-02-08, SEC form D sold, 16 investors
Round, 2013: $900K2013-01-16, SEC form D sold, 9 investors
Round, 2012: $900K2012-12-05, SEC form D sold, 9 investors
Round, 2012: $5M2012-02-08, SEC form D sold, 8 investors
Round, 2010: $455K2010-10-15, SEC form D sold, 1 investor
Round, 2010: $15.6M2010-05-05, SEC form D sold, 7 investors
Round, 2009: $1.5M2009-11-04, SEC form D sold, 7 investors